Truvada prevents HIV infection in high-risk individuals! A clinical success built on animal research | Speaking of Research

In the past two weeks we’ve learned of a major advance in ongoing efforts to halt the spread of  HIV, two separate clinical studies have reported that a daily regimen of a pill called Truvada as a pre-exposure prophylaxis (PrEP) is highly effective in preventing infection in high risk groups. This success is a result…

Sourced through Scoop.it from: speakingofresearch.com

See on Scoop.itCuriosopernatura

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *